Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-22T17:44:15.988Z Has data issue: false hasContentIssue false
  • English
  • Français

Neurodevelopmental markers in different psychopathological dimensions of first episode psychosis: The ESPIGAS Study

Published online by Cambridge University Press:  16 April 2020

Miguel Ruiz-Veguilla ,
Jorge A. Cervilla ,
Maria Luisa Barrigón ,
Maite Ferrín ,
Blanca Gutiérrez ,
Estibaliz Gordo ,
Manuel Anguita ,
Antía Brañas ,
Jesús Fernández-Logroño  and
Manuel Gurpegui
Miguel Ruiz-Veguilla
Affiliation:
First Episode and Early Onset Psychosis Unit, Unidad de Psiquiatria, Hospital Neurotraumatológico, Complejo Hospitalario de Jaen, E-23009Jaen, Spain
Jorge A. Cervilla*
Affiliation:
Departamento de Medicina Legal, Toxicología y Psiquiatría, Instituto de Neurociencias, Facultad de Medicina, Universidad de Granada, Avenida de Madrid, 11, E-18071Granada, Spain
Maria Luisa Barrigón
Affiliation:
Hospital Clínico San Cecilio, Avda. del Dr. Oloriz n°16, E-18012Granada, Spain
Maite Ferrín
Affiliation:
Unidad de Psiquiatria, Hospital Neurotraumatológico, Unidad de Salud Mental Infanto-juvenil, Avenida, Doctor Olóriz 16, Complejo Hospitalario de Jaen, E-23009Jaen, Spain
Blanca Gutiérrez
Affiliation:
Departamento de Medicina Legal, Toxicología y Psiquiatría, Instituto de Neurociencias, Facultad de Medicina, Universidad de Granada, Avenida de Madrid, 11, E-18071Granada, Spain
Estibaliz Gordo
Affiliation:
Hospital Clínico San Cecilio, Avda. del Dr. Oloriz n°16, E-18012Granada, Spain
Manuel Anguita
Affiliation:
Hospital Clínico San Cecilio, Avda. del Dr. Oloriz n°16, E-18012Granada, Spain
Antía Brañas
Affiliation:
Hospital Clínico San Cecilio, Avda. del Dr. Oloriz n°16, E-18012Granada, Spain
Jesús Fernández-Logroño
Affiliation:
Hospital Clínico San Cecilio, Avda. del Dr. Oloriz n°16, E-18012Granada, Spain
Manuel Gurpegui
Affiliation:
Departamento de Medicina Legal, Toxicología y Psiquiatría, Instituto de Neurociencias, Facultad de Medicina, Universidad de Granada, Avenida de Madrid, 11, E-18071Granada, Spain
*
*Corresponding author. Tel./fax: +34 958 241 017. E-mail address: [email protected] (M. Ruiz-Veguilla), [email protected] (J.A. Cervilla), [email protected] (M.L. Barrigón), [email protected] (M. Ferrín), [email protected] (B. Gutiérrez), [email protected] (E. Gordo), [email protected] (M. Anguita), [email protected] (A. Brañas), [email protected] (J. Fernández-Logroño), [email protected] (M. Gurpegui).
Get access

Abstract

Objective

The main aim of this study was to explore whether specific groups of patients with first episode non-affective psychosis could be identified on a psychopathological basis and, then, whether such identified groups could be validated by exploring their correlation with a variety of neurodevelopmental markers.

Method

Eighty-seven patients with a first episode of non-affective psychotic disorder were consecutively recruited. We assessed psychopathology and neurological soft signs using the PANSS and the Neurological Evaluation Scale, respectively. We collected information on obstetric complications, premorbid adjustment and family history.

Results

All PANSS symptoms were analysed using principal component analysis and four factors were obtained (negative, disorganization, positive and paranoid). Subsequently, the four factors were subjected to a cluster analysis where three groups emerged: “paranoid” (n = 40), “low score” (n = 29) and “negative” (n = 18) subtype. After adjusting by sex and age, we found that the “negative group” had poorer social premorbid adjustment, worse verbal fluency and higher prevalence of both obstetric complications and neurological soft signs, when compared with the “low score” group. Similarly, the “negative group” showed significantly poorer social premorbid adjustment and higher number of neurological soft signs than the “paranoid group”.

Conclusions

Our results support that, among non-affective first onset psychotic patients, those with predominant negative symptoms are more likely to correlate with higher presence of neurodevelopmental markers.

Keywords

First episode psychosisNeurodevelopmentalNeurological soft signsCluster analysis
Type
Original article
Information
European Psychiatry , Volume 23 , Issue 8 , December 2008 , pp. 533 - 540
Copyright
Copyright © Elsevier Masson SAS 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatry Association, Diagnostic and Statistical Manual of Mental Disorders 4th ed.Washington, DC: APA; 2000. DSM-IV.TRGoogle Scholar
Bleuler, .Dementia Praecox oder Gruppe der Schizophrenien. Leipzig and Vienna: Verlag Franz Deutike (Translated by Zinkin J Dementia Praecox or the group of schizophrenias New York: International Universities Press; 1911. 1950)Google Scholar
Buchanan, R.Heinrichs, D.The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia Psychiatry Res. 27 1989 335–350CrossRefGoogle Scholar
Caligiuri, M.Lorh, J.A disturbance in the control of muscle in neuroleptic-naïve schizophrenic patients Biol Psychiatry. 35 1994 104–111CrossRefGoogle ScholarPubMed
Cannon, .Jones, P.Murray, R.Obstetric complications and schizophrenia: historical and metanalytic review Am J Psychiatr. 159 2002 1080–1092CrossRefGoogle Scholar
Cannon-Spoor, H.Potkin, S.Wyatt, R.Measurement of premorbid adjustment in chronic schizophrenia Schizophr Bull. 8 1982 470–484CrossRefGoogle ScholarPubMed
Dazzan, .Morgan, K.Orr, K.Hutchinson, .Chitnis, .Suckling, .et al.The structural brain correlates of neurological soft signs in AESOP first episode psychoses study Brain. 127 2004 143–153CrossRefGoogle ScholarPubMed
DeLisi, L.The significance of age of onset for schizophrenia Schizophr Bull. 18 1992 209–215CrossRefGoogle Scholar
Dollfus, .Everitt, .Ribeyre, J.Assouly-Besse, .Sharp, .Petit, .Identifying subtypes of schizophrenia by cluster analyses Schizophr Bull. 22 1996 545–555CrossRefGoogle ScholarPubMed
Edwards, .McGorry, P.Waddell, F.Harrigan, S.Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data Schizophr Res. 40 1999 147–158CrossRefGoogle ScholarPubMed
Emsley, .Rabinowitz, .Torreman, .RIS-INT-35 Early Psychosis Global Working Group. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis Schizophr Res. 61 2003 47–57CrossRefGoogle Scholar
Farmer, A.McGuffin, .Spitznagel, E.Heterogeneity in schizophrenia: a cluster-analytic approach Psychiatry Res. 8 1983 1–12CrossRefGoogle ScholarPubMed
First, M.Spitzer, R.Gibbon, .Williams, J.Benjamin, L.Structured clinical interview for DSM-IV axis 1 disorders (clinician version) Washington, DC: American Psychiatry Association; 1994.Google Scholar
Geddes, J.Verdoux, .Takei, .Lawrie, S.Bovet, .Eagles, J.et al.Schizophrenia and complications of pregnancy and labor: an individual-patient data meta-analysis Schizophr Bull. 25 1999 413–423CrossRefGoogle ScholarPubMed
Graig, T.Bromet, E.Fenning, .Tanenberg-Karant, .Lavelle, .Galambos, .Is there an association between duration of untreated psychosis and 24 month clinical outcome in a first-admission series? Am J Psychiatry. 157 2000 60–66Google Scholar
Guerra, .Fearon, .Sham, .Jones, .Lewis, .Mata, .et al.The relationship between predisposing factors, premorbid function and symptom dimensions in psychosis: an integrated approach Eur Psychiatry. 17 2002 311–320CrossRefGoogle ScholarPubMed
Jones, S.Thornicroft, .Coffey, .Dunn, .A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF) Br J Psychiatry. 166 1995 654–659CrossRefGoogle Scholar
Kay, .Fiszbein, .Opler, L.The Positive and Negative Syndrome Scale for Schizophrenia Schizophr Bull. 13 1987 261–278CrossRefGoogle Scholar
Kelley, M.Gilbertson, .Mouton, .van Kammen, D.Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients Am J Psychiatry. 149 1992 1543–1548Google ScholarPubMed
Kendler, K.Davis, K.The genetics and biochemistry of paranoid schizophrenia and other paranoid psychosis Schizophr Bull. 7 1981 689–709CrossRefGoogle Scholar
Kendler, K.Gruenherg, A.Tsuang, M.A family study of subtypes of schizophrenia Am J Psychiatry. 146 1988 953–962Google Scholar
Kotlicka-Antczak, .Gmitrowicz, .Sobów, T.Rabe-Jabłonska, .Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms J Psychiatry Res. 35 2001 249–257CrossRefGoogle ScholarPubMed
Larsen, T.Moe, L.Vibe-hansen, .Johannessen, J.Premorbid functioning versus duration of untreated psychosis in one year outcome in first-episode psychosis Schizophr Res. 45 2000 1–9CrossRefGoogle Scholar
Lastra, .Vazquez-Barquero, J.Herrera Castanedo, .Cuesta, M.Vázquez-Bourgon, M.Dunn, .The classification of first episode schizophrenia: a cluster-analytical approach Acta Psychiatr Scand. 102 2000 26–31CrossRefGoogle ScholarPubMed
Lewis, .Murray, R.Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia J Psychiatr Res. 21 1987 413–421CrossRefGoogle ScholarPubMed
Lykouras, .Oulis, .Daskalopoulou, .Psarros, .Christodoulou, G.2001 Clinical subtypes of schizophrenic disorders: a cluster analytic study Psychopathology. 34 2001 23–28CrossRefGoogle ScholarPubMed
Malla, A.Takhar, J.Norman, R.Manchanda, .Cortese, .Haricharan, .et al.Negative symptoms in first episode non-affective psychosis Acta Psychiatr Scand. 105 2002 431–439CrossRefGoogle ScholarPubMed
Manschreck, T.Ames, .Neurologic features and psychopathology in schizophrenic disorders Biol Psychiatry. 19 1984 703–719Google ScholarPubMed
Maxwell, M.Family Interview for Genetic Studies (FIGS): a manual for FIGS, clinical neurogenetics branch, intramural research program Bethesda, Maryland: National Institute of Mental Health; 1992.Google Scholar
Morgan, .Abdul-Al, .Lappin, J.Fearon, .Leese, .Croudace, .et al.AESOP study Group. Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study Br J Psychiatry. 189 2006 446–452CrossRefGoogle Scholar
Murray, R.Cervilla, .Esquizofrenia por Neurodesarrollo anormal: voces del pasado Arch Neurobiol. 59 1996 223–234Google Scholar
Murray, R.Lewis, S.Is schizophrenia a neurodevelopmental disorder? Br Med J. 296 1987 681–682CrossRefGoogle Scholar
Murray, R.O'Callaghan, .Castle, D.Lewis, S.A neurodevelopmental approach to the classification of schizophrenia Schizophr Bull. 18 1992 319–332CrossRefGoogle ScholarPubMed
Norma, R.Malla, A.Duration of untreated psychosis: a critical examination of the concept and its importance Psychol Med. 31 2003 381–400CrossRefGoogle Scholar
Norman, R.Malla, A.Manchanda, .Townsend, .Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains Acta Psychiatr Scand. 112 2002 30–39CrossRefGoogle Scholar
Peralta, .Cuesta, M.Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia Psychiatry Res. 53 1994 31–34CrossRefGoogle Scholar
Peralta, .Cuesta, M.The underlying structure of diagnostic systems of schizophrenia: a comprehensive polydiagnostic approach Schizophr Res. 79 2005 217–219CrossRefGoogle ScholarPubMed
Sham, P.Castle, J.Wessely, .Farmer, A.Murray, R.Further exploration of a latent class typology of schizophrenia Schizophr Res. 20 1996 105–115CrossRefGoogle ScholarPubMed
Tosato, .Dazzan, .The psychopathology of schizophrenia and the presence of neurological soft signs: a review Curr Opin Psychiatry. 18 2005 285–288CrossRefGoogle ScholarPubMed
Tsuang, M.Lyons, M.Faraone, S.Heterogeneity of schizophrenia: Conceptual models and analytic strategies Br J Psychiatry. 156 1990 117–126CrossRefGoogle ScholarPubMed
Uçok, .Polat, .Cakir, .Genç, .One year outcome in first episode schizophrenia. Predictors of relapse Eur Arch Psychiatry Clin Neurosci. 256 2006 37–43CrossRefGoogle Scholar
van Os, .Gilvarry, .Bale, .Van Horn, .Tattan, .et al.A comparison of utility of dimensional and categorical representations of psychosis Psychol Med. 29 1999 595–06CrossRefGoogle Scholar
Wong, A.Voruganti, L.Heslegrave, R.Awad, A.Neurocognitive deficits and neurological signs in schizophrenia Schizophr Res. 23 1997 139–146CrossRefGoogle Scholar
World Health Organization, Composite International Diagnostic Interview (CIDI), version 1.1 Geneva: Switzerland; 1993.Google Scholar
Submit a response

Comments

No Comments have been published for this article.